Share this Story

WEDNESDAY, (HealthDay News) — In the U.S, 5-and 10-year survival rates is improving for children younger than age 15 suffering from acute lymphoblastic leukemia (ALL), or non Hodgkin lymphoma (NHL), says a new study published in the Journal of the National Cancer Institute.

Advance treatments for such diseases have enhanced long-term survival for patients. But study includes survival data from patients diagnosed in late nineties or before and, hence, may not be able to clear current situation.

In order to assess current outcomes, researchers examine 5- and 10-year survival estimates for those, diagnosed in 1990-94, 1995-99, and 2000-04, and also developed methods to forecast chances of survival in patients diagnosed in 2005-09.

The researchers came to know that from 1990-94 and 2000-04, 5- and 10-year survival amplified from 80.2 percent to 87.5 percent and from 73.4 percent to 83.8 percent, respectively. In patients with ALL chances increase from 41.9 percent to 59.9 percent and from 38.7 and for patients with acute NHL these increase from 76.6 percent to 87.7 respectively.

For children diagnosed in 2005, the estimated 10-year survival rate was 88.0 percent for ALL and 90.6 percent for NHL patients.

“Our period analysis revealed that survival after diagnosis with childhood hematologic malignancies has improved greatly over the past decade,” the study authors concluded. “Improvements in survival in childhood hematologic malignancies are most likely attributable to changes in how these diseases are treated.”

All articles published in AllinfoDir Articles are property of the site only, copying and publishing is strictly against the policy of the site and strictly prohibited.

Leave a Reply